Data / Research funding / Orthopoxviruses
Orthopoxviruses: 36 NIH awards ($75.8M) to 29 organizations
36 NIH awards ($75.8M) in the NIH spending category Orthopoxviruses, to 29 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
36 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Task V15: Development of Assays and Reagents for mpox Vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $28,751,383 | September 1, 2022 | April 30, 2026 | RUDGE, THOMAS | reporter.nih.gov |
| B-CELL EPITOPE DISCOVERY AND MECHANISMS OF ANTIBODY PROTECTION | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $5,936,710 | September 16, 2019 | August 31, 2025 | CROWE, JAMES E | reporter.nih.gov |
| Advancement of a poxvirus antiviral | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,192,454 | March 12, 2020 | August 31, 2029 | CONNOR, JOHN H | reporter.nih.gov |
| Novel Translational Control Mechanisms in Host Range Restriction of Poxvirus | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,420,139 | September 22, 2020 | August 31, 2030 | XIANG, YAN | reporter.nih.gov |
| Viral inhibition of cell death in host immune responses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,337,050 | June 22, 2020 | May 31, 2025 | MIAO, EDWARD A | reporter.nih.gov |
| Biomarker Identification, Viral Susceptibility and Management in S. aureus Colonized AD Patients | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,310,254 | April 6, 2020 | March 31, 2027 | BECK, LISA ANN | reporter.nih.gov |
| Poxvirus manipulation of the host cell protein synthesis machinery | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,267,115 | November 23, 2016 | December 31, 2026 | WALSH, DEREK | reporter.nih.gov |
| IL-27-producing B cells in the antibody response | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,209,265 | February 2, 2021 | January 31, 2027 | XU, ZHENMING | reporter.nih.gov |
| Mechanisms of protective memory CD8 T-cell induction by mRNA-LNP vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,140,211 | June 1, 2023 | May 31, 2028 | SIGAL, LUIS J | reporter.nih.gov |
| Monkeypox virus, Interferon, and Necroptosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,856,868 | May 24, 2012 | July 31, 2025 | JACOBS, BERTRAM L. | reporter.nih.gov |
| Development of novel antivirals against mpox (monkeypox) virus | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,550,961 | June 14, 2024 | April 30, 2029 | WANG, ZHENGQIANG | reporter.nih.gov |
| Discovery of Antivirals Targeting Mpox Virus | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,549,199 | May 8, 2024 | March 31, 2029 | SARAFIANOS, STEFAN G | reporter.nih.gov |
| Vertical transmission, pregnancy outcomes and treatment of Mpox virus infection in a translational pregnant macaque model | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,487,989 | February 19, 2024 | December 31, 2028 | MOHR, EMMA L | reporter.nih.gov |
| Molecular mechanisms and ramifications of horizontal gene transfer into poxviruses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,483,958 | February 18, 2020 | January 31, 2026 | ROTHENBURG, STEFAN | reporter.nih.gov |
| The B22 family of orthopoxvirus virulence factors: Investigating structure/function of these potent, multifaceted immunoevasins | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,462,194 | February 6, 2024 | December 31, 2028 | EISENLOHR, LAURENCE CRANE | reporter.nih.gov |
| New mechanisms governing skin tissue residency memory T cells | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,428,241 | April 1, 2024 | March 31, 2029 | ANANDASABAPATHY, NIROSHANA | reporter.nih.gov |
| Subversion of Cellular Mitotic and Antiviral Signaling by Poxviral Kinases | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,331,244 | December 3, 2022 | November 30, 2027 | WIEBE, MATTHEW S | reporter.nih.gov |
| The role of mTOR dysregulation in poxvirus infection | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,315,135 | November 17, 2023 | October 31, 2028 | WALSH, DEREK | reporter.nih.gov |
| TASK ORDER B03: EVALUATION OF ANTIVIRAL DRUG CANDIDATES AGAINST MPOX IN NHPS | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,258,076 | September 30, 2025 | September 29, 2026 | SIVKO, GLORIA | reporter.nih.gov |
| Gigapixel Next-Generation-Sequencing: An Ultra-Sensitive Diagnostic for Infections of the CNS | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,221,032 | November 1, 2023 | October 31, 2027 | ABATE, ADAM R. | reporter.nih.gov |
| Understanding the Function of F13 as a Matrix Protein for Poxvirus Intracellular Envelopment | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,143,450 | February 10, 2023 | January 31, 2027 | WARD, BRIAN M | reporter.nih.gov |
| Defining Ocular Monkey Pox Pathogenic Mechanisms | NIH | National Eye Institute | 2025 | $713,991 | July 1, 2025 | June 30, 2030 | ARUMUGASWAMI, VAITHILINGARAJA | reporter.nih.gov |
| Discovery of antiviral inhibitors for the treatment of orthopoxvirus infections | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $600,000 | July 24, 2023 | December 31, 2025 | COBURN, GLEN | reporter.nih.gov |
| Microneedle patch delivery of replication-inducible monkeypox vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $547,988 | August 11, 2025 | July 31, 2030 | GAMBOTTO, ANDREA | reporter.nih.gov |
| Emerging and Re-Emerging Pathogens Research Training Program in DRC (EREP-RTP-DRC) | NIH | Fogarty International Center | 2024 to 2025 | $495,039 | June 1, 2024 | May 31, 2029 | MUYEMBE-TAMFUM, JEAN-JACQUES TAMFUM | reporter.nih.gov |
| Decoding the Molecular and Antigenic Interactions in Orthopox Virus Entry | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $466,125 | August 1, 2025 | July 31, 2027 | DUERR, RALF | reporter.nih.gov |
| Comprehensive genetic dissection of poxvirus membrane assembly and function | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $462,000 | December 1, 2022 | November 30, 2025 | CHANDRAN, KARTIK | reporter.nih.gov |
| Safer, More Effective Mpox/Smallpox Vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $431,750 | August 1, 2025 | July 31, 2027 | JACOBS, BERTRAM L. | reporter.nih.gov |
| Genomic Surveillance of Mpox through the Development of a Wastewater Intelligence Model and Data Analytics Platform | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $416,625 | August 7, 2025 | July 31, 2027 | OH, EDWIN C. | reporter.nih.gov |
| Poxvirus-encoded noncanonical open reading frames | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $404,584 | May 5, 2023 | April 30, 2026 | YANG, ZHILONG | reporter.nih.gov |
| APOBEC3-driven host mechanism promotes poxvirus diversification to overcome host immune restriction | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $221,105 | May 1, 2025 | April 30, 2027 | LIU, JIA | reporter.nih.gov |
| Establishing Human 2D and 3D Testicular Models to Elucidate Monkeypox Virus Tropism and Pathogenic Mechanisms in the Testes | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $156,500 | August 1, 2025 | July 31, 2027 | VERMA, SAGUNA | reporter.nih.gov |
| Antiviral Resistance to Acyclic Phosphonates in Orthopoxviruses | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $80,224 | September 11, 2025 | September 10, 2028 | LEE, JASPER | reporter.nih.gov |
| Epidemiological factors related to human monkeypox virus (MPOX) in men who have sex with men (MSM) in the United States | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $48,974 | June 1, 2024 | March 10, 2025 | CARPINO, THOMAS | reporter.nih.gov |
| Characterization of a sensor domain for cytoplasmic nucleic acid in the antiviral factor, SAMD9 | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $38,314 | September 1, 2024 | August 31, 2025 | MORALES, MARISOL | reporter.nih.gov |
| Uncovering the molecular underpinnings of C15, a potent orthopoxvirus virulence factor | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $36,803 | August 1, 2024 | July 31, 2025 | CARRO, STEPHEN DAVID | reporter.nih.gov |
Organizations
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 26 | $17,741,419 | 0 | $0 |
| 2024 | 28 | $25,107,112 | 0 | $0 |
| 2023 | 16 | $11,285,996 | 0 | $0 |
| 2022 | 10 | $13,400,994 | 0 | $0 |
| 2021 | 10 | $8,237,429 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 30 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 30 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 30 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 30 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 30 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 30 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 30 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 30 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 30 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 30 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 30 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 30 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 30 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 30 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 30 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 30 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 30 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 30 awards here |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | PA-24-185 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 30 awards here |
| Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required) | PA-24-187 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 30 awards here |
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.